Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Воспалительные заболевания органов малого таза: состояние проблемы
________________________________________________
Kuznetsov R.E., Skripchenko D.V. A modern overview on the diagnosis and treatment of pelvic inflammatory diseases. Consilium Medicum. 2019; 21 (6): 63–67. DOI: 10.26442/20751753.2019.6.190565
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: воспалительные заболевания органов малого таза, осложнения, принципы терапии.
________________________________________________
Key words: pelvic inflammatory diseases, complications, principles of therapy.
[Obstetrics and gynecology. Ed. by V.N.Serov, G.T.Sukhikh. Ed. 4th, rev. and ext., Moscow: GEOTAR-Media, 2014 (in Russian).]
2. Ross J, Judlin P, Jensen J. European guideline for the management of pelvic inflammatory disease, International Union against sexually transmitted infections. Int J STD AIDS 2014; 25: 1–7.
3. Гопчук Е.Н. Воспалительные заболевания органов малого таза. Здоровье женщины. 2015; 8: 159.
[Gopchuk E.N. Vospalitel'nye zabolevaniia organov malogo taza. Zdorov'e zhenshchiny. 2015; 8: 159 (in Russian).]
4. Уткин Е.В., Кулавский В.А. Воспалительные заболевания органов малого таза у женщин. М.: ГЭОТАР-Медиа, 2015.
[Utkin E.V., Kulavskiy V.A. Inflammatory diseases of the pelvic organs in women. Moscow: GEOTAR-Media, 2015 (in Russian).]
5. Ozdemirci S, Demirdag E, Kasapoglu T et al. Obstetric outcome of second trimester antenatal bleeding. J Matern Fetal Neonatal Med 2016; 4: 1–5.
6. Долгушина В.Ф., Шишкова Ю.С., Графова Е.Д. и др. Инфекционная патология влагалища и шейки матки у женщин со спонтанными преждевременными родами. Урал. мед. журн. 2017; 1: 62–4.
[Dolgushina V.F., Shishkova Iu.S., Grafova E.D. et al. Infektsionnaia patologiia vlagalishcha i sheiki matki u zhenshchin so spontannymi prezhdevremennymi rodami. Ural. med. zhurn. 2017; 1: 62–4 (in Russian).]
7. Чаунин А.В. Гнойные воспалительные заболевания придатков матки у женщин репродуктивного возраста: диагностика, современные принципы лечения. Автореф. дис. ... канд. мед. наук. Омск, 2010; с. 19–22.
[Chaunin A.V. Gnoinye vospalitel'nye zabolevaniia pridatkov matki u zhenshchin reproduktivnogo vozrasta: diagnostika, sovremennye printsipy lecheniia. Avtoref. dis. ... kand. med. nauk. Omsk, 2010; p. 19–22 (in Russian).]
8. Asemota OA, Girda E, Duenas O et al. Actinomycosis pelvic abscess after in vitro fertilization. Fertil Steril 2013; 100 (2): 408–11.
9. Moralioğlu S, Ozen IO, Demiroğullari B, Başaklar AC. Pyosalpinx and hydrosalpinx in virginal adolescents: report of two cases. West Indian Med J 2013; 62 (3): 257–9.
10. Хаятова З.Б., Пекарев О.Г. Проблема воспалительных заболеваний органов малого таза у женщин репродуктивного возраста. Journal of Siberian Medical Sciences. 2011; 4: 3–10.
[Khaiatova Z.B., Pekarev O.G. Problema vospalitel'nykh zabolevanii organov malogo taza u zhenshchin reproduktivnogo vozrasta. Journal of Siberian Medical Sciences. 2011; 4: 3–10 (in Russian).]
11. Bugg CW, Taira T. Pelvic Inflammatory Disease: Diagnosis And Treatment In The Emergency Department. Emerg Med Pract 2016; 18: 1–24.
12. Dewitt J, Reining A, Allsworth JE, Peipert JF. Tuboovarian abscesses: is size associated with duration of hospitalization & complications? Obstet Gynecol Int 2010; p. 1–5.
13. Kinay T, Unlubilgin E, Cirik DA et al. The value of ultrasonographic tubo-ovarian abscess morphology in predicting whether patients will require surgical treatment. Int J Gynecol Obs 2016; 135 (1): 77–81.
14. Kapustian V, Namazov A, Yaakov O et al. Is intrauterine device a risk factor for failure of conservative management in patients with tubo-ovarian abscess? An observational retrospective study. Arch Gynecol Obs 2018; 297 (5): 1201–4.
15. Straub T, Reynaud M, Yaron M. Intrauterine device and pelvic inflammatory disease: Myth or reality? Gynecol Obstet Fertil Senol 2018; 46 (4): 414–8.
16. Güngördük K, Guzel E, Asicioğlu O et al. Experience of tubo-ovarian abscess in western Turkey. Int J Gynecol Obstet 2014; 124 (1): 45–50.
17. Kuo CF, Tsai SY, Liu TC et al. Clinical characteristics and treatment outcomes of patients with tubo-ovarian abscess at a tertiary care hospital in Northern Taiwan. J Microbiol Immunol Infect 2012; 45 (1): 58–64.
18. Patrelli TS, Franchi L, Gizzo S et al. Can the impact of pelvic inflammatory disease on fertility be prevented? Epidemiology, clinical features and surgical treatment: evolution over 8 years. J Reprod Med 2013, 58 (9–10): 425–33.
19. Karaca K, Ozkaya E, Kurek Eken M et al. Serum procalcitonin levels together with clinical features and inflammatory markers in women with tubo-ovarian abscess for discriminating requirements for surgery for full recovery. J Obstet Gynaecol 2018; 38 (6): 818–21.
20. Дикке Г.Б. Полимикробные ассоциации в этиологии воспалительных заболеваний половых органов у женщин. Акушерство и гинекология. 2017; 6: 151–8.
[Dikke G.B. Polimikrobnye assotsiatsii v etiologii vospalitel'nykh zabolevanii polovykh organov u zhenshchin. Akusherstvo i ginekologiia. 2017; 6: 151–8 (in Russian).]
21. Revzin MV, Mathur M, Dave HB et al. Pelvic Inflammatory Disease: Multimodality Imaging Approach with Clinical-Pathologic Correlation. RadioGraphics 2016; 36 (5): 1579–96.
22. Lanjouw E, Ouburg S, de Vries HJ et al. Background review for the “2015 European guideline on the management of Chlamydia trachomatis infections”. Int J STD AIDS 2015; 86: 91–8.
23. Oakeshott P, Aghaizu A, Hay P et al. Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study. Clin Infect Dis 2010; 51: 1160–6.
24. Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med 2015; 372: 2039–48.
25. Hunanyan AR, Sidorova IS, Kogan EA. The role of the combination of HPV infection and chronic endometritis in the pathogenesis of endometrial cancer. StatusPraesens 2012; 3: 23–6.
26. Гинекология. Национальное руководство. Под ред. Г.М.Савельевой, Г.Т.Сухих, В.Н.Серова. М.: ГЭОТАР-Медиа, 2019.
[Gynecology. National leadership. Ed. by G.M.Savelieva, G.T.Sukhikh, V.N.Serov. Moscow: GEOTAR-Media, 2019 (in Russian).]
27. Войновский Е.А., Гафуров Ю.Т., Евсюков O.A. и др. Воспалительные заболевания органов малого таза у ВИЧ-инфицированных больных. Мед. вестник МВД. 2014; 1: 44–8.
[Voinovskii E.A., Gafurov Iu.T., Evsiukov O.A. et al. Vospalitel'nye zabolevaniia organov malogo taza u VICh-infitsirovannykh bol'nykh. Med. vestnik MVD. 2014; 1: 44–8 (in Russian).]
28. Wang Y, Zhang Y, Zhang Q, Chen H. Characterization of pelvic and cervical microbiotas from patients with pelvic inflammatory disease. Med Microbiol 2018; 67 (10): 1519–26.
29. Czeyda-Pommersheim F, Kalb B, Costello J et al. MRI in pelvic inflammatory disease: a pictorial review. Abdominal Radiol 2016; 42 (3): 935–50.
30. Подзолкова Н.М. Патогенез, диагностика и лечение гнойных воспалительных заболеваний придатков матки. Дис. … д-ра мед. наук. М., 1993; с. 110–6.
[Podzolkova N.M. Patogenez, diagnostika i lechenie gnoinykh vospalitel'nykh zabolevanii pridatkov matki. Dis. … d-ra med. nauk. M., 1993; p. 110–6 (in Russian).]
31. Janas P, Kucybata I, Padon-Pokracka M, Huras H. Telocytes in female reproductive system: An overview of up-to-date knowledge. Adv Clin Exp Med 2018; 27: 559–65.
32. Varga I, Urban L, Kajanova M, Polak S. Functional histology and possible clinical significance of recently discovered telocytes inside the female reproductive system. Arch Gynecol Obstet 2016; 294: 417–22.
33. Yang J, Chi C, Liu Z et al. Ultrastructure damage of oviduct telocytes in rat model of acute salpingitis, J Cell Mol Med 2015; 19 (7): 1720–8.
34. Enciu AM, Popescu LM. Telopodes of telocytes are influenced in vitro by redox conditions and ageing. Mol Cell Biochem 2015; 410 (1–2): 165–74.
35. Duarte R, Fuhrich D, Ross J. A review of antibiotic therapy for pelvic inflammatory disease. Int J Antimicrob Agents 2015; 46: 272–7.
36. Chappell CA, Wiesenfeld HC. Pathogenesis, Diagnosis, and Management of Severe Pelvic Inflammatory Disease and Tuboovarian Abscess. Clin Obstet Gynecol 2012; 55 (4): 893–903.
37. Chu J, Harb HM, Gallos ID et al. Salpingostomy in the treatment of hydrosalpinx: a systematic review and meta-analysis. Human Rep 2015; 30 (8): 1882–95.
38. Lee MH, Moon MH, Sung CK et al. CT findings of acute pelvic inflammatory disease. Abdom Imag 2014; 39 (6): 1350–5.
39. Levenson RB, Camacho MA, Horn E et al. Eliminating routine oral contrast use for CT in the emergency department: impact on patient throughput and diagnosis. Emerg Radiol 2012; 19 (6): 513–7.
40. Sam JW, Jacobs JE, Birnbaum BA. Spectrum of CT findings in acute pyogenic pelvic inflammatory disease. RadioGraphics 2002; 22 (6): 1327–34.
________________________________________________
1. Obstetrics and gynecology. Ed. by V.N.Serov, G.T.Sukhikh. Ed. 4th, rev. and ext., Moscow: GEOTAR-Media, 2014 (in Russian).
2. Ross J, Judlin P, Jensen J. European guideline for the management of pelvic inflammatory disease, International Union against sexually transmitted infections. Int J STD AIDS 2014; 25: 1–7.
3. Gopchuk E.N. Vospalitel'nye zabolevaniia organov malogo taza. Zdorov'e zhenshchiny. 2015; 8: 159 (in Russian).
4. Utkin E.V., Kulavskiy V.A. Inflammatory diseases of the pelvic organs in women. Moscow: GEOTAR-Media, 2015 (in Russian).
5. Ozdemirci S, Demirdag E, Kasapoglu T et al. Obstetric outcome of second trimester antenatal bleeding. J Matern Fetal Neonatal Med 2016; 4: 1–5.
6. Dolgushina V.F., Shishkova Iu.S., Grafova E.D. et al. Infektsionnaia patologiia vlagalishcha i sheiki matki u zhenshchin so spontannymi prezhdevremennymi rodami. Ural. med. zhurn. 2017; 1: 62–4 (in Russian).
7. Chaunin A.V. Gnoinye vospalitel'nye zabolevaniia pridatkov matki u zhenshchin reproduktivnogo vozrasta: diagnostika, sovremennye printsipy lecheniia. Avtoref. dis. ... kand. med. nauk. Omsk, 2010; p. 19–22 (in Russian).
8. Asemota OA, Girda E, Duenas O et al. Actinomycosis pelvic abscess after in vitro fertilization. Fertil Steril 2013; 100 (2): 408–11.
9. Moralioğlu S, Ozen IO, Demiroğullari B, Başaklar AC. Pyosalpinx and hydrosalpinx in virginal adolescents: report of two cases. West Indian Med J 2013; 62 (3): 257–9.
10. Khaiatova Z.B., Pekarev O.G. Problema vospalitel'nykh zabolevanii organov malogo taza u zhenshchin reproduktivnogo vozrasta. Journal of Siberian Medical Sciences. 2011; 4: 3–10 (in Russian).
11. Bugg CW, Taira T. Pelvic Inflammatory Disease: Diagnosis And Treatment In The Emergency Department. Emerg Med Pract 2016; 18: 1–24.
12. Dewitt J, Reining A, Allsworth JE, Peipert JF. Tuboovarian abscesses: is size associated with duration of hospitalization & complications? Obstet Gynecol Int 2010; p. 1–5.
13. Kinay T, Unlubilgin E, Cirik DA et al. The value of ultrasonographic tubo-ovarian abscess morphology in predicting whether patients will require surgical treatment. Int J Gynecol Obs 2016; 135 (1): 77–81.
14. Kapustian V, Namazov A, Yaakov O et al. Is intrauterine device a risk factor for failure of conservative management in patients with tubo-ovarian abscess? An observational retrospective study. Arch Gynecol Obs 2018; 297 (5): 1201–4.
15. Straub T, Reynaud M, Yaron M. Intrauterine device and pelvic inflammatory disease: Myth or reality? Gynecol Obstet Fertil Senol 2018; 46 (4): 414–8.
16. Güngördük K, Guzel E, Asicioğlu O et al. Experience of tubo-ovarian abscess in western Turkey. Int J Gynecol Obstet 2014; 124 (1): 45–50.
17. Kuo CF, Tsai SY, Liu TC et al. Clinical characteristics and treatment outcomes of patients with tubo-ovarian abscess at a tertiary care hospital in Northern Taiwan. J Microbiol Immunol Infect 2012; 45 (1): 58–64.
18. Patrelli TS, Franchi L, Gizzo S et al. Can the impact of pelvic inflammatory disease on fertility be prevented? Epidemiology, clinical features and surgical treatment: evolution over 8 years. J Reprod Med 2013, 58 (9–10): 425–33.
19. Karaca K, Ozkaya E, Kurek Eken M et al. Serum procalcitonin levels together with clinical features and inflammatory markers in women with tubo-ovarian abscess for discriminating requirements for surgery for full recovery. J Obstet Gynaecol 2018; 38 (6): 818–21.
20. Dikke G.B. Polimikrobnye assotsiatsii v etiologii vospalitel'nykh zabolevanii polovykh organov u zhenshchin. Akusherstvo i ginekologiia. 2017; 6: 151–8 (in Russian).
21. Revzin MV, Mathur M, Dave HB et al. Pelvic Inflammatory Disease: Multimodality Imaging Approach with Clinical-Pathologic Correlation. RadioGraphics 2016; 36 (5): 1579–96.
22. Lanjouw E, Ouburg S, de Vries HJ et al. Background review for the “2015 European guideline on the management of Chlamydia trachomatis infections”. Int J STD AIDS 2015; 86: 91–8.
23. Oakeshott P, Aghaizu A, Hay P et al. Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study. Clin Infect Dis 2010; 51: 1160–6.
24. Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med 2015; 372: 2039–48.
25. Hunanyan AR, Sidorova IS, Kogan EA. The role of the combination of HPV infection and chronic endometritis in the pathogenesis of endometrial cancer. StatusPraesens 2012; 3: 23–6.
26. Gynecology. National leadership. Ed. by G.M.Savelieva, G.T.Sukhikh, V.N.Serov. Moscow: GEOTAR-Media, 2019 (in Russian).
27. Voinovskii E.A., Gafurov Iu.T., Evsiukov O.A. et al. Vospalitel'nye zabolevaniia organov malogo taza u VICh-infitsirovannykh bol'nykh. Med. vestnik MVD. 2014; 1: 44–8 (in Russian).]
28. Wang Y, Zhang Y, Zhang Q, Chen H. Characterization of pelvic and cervical microbiotas from patients with pelvic inflammatory disease. Med Microbiol 2018; 67 (10): 1519–26.
29. Czeyda-Pommersheim F, Kalb B, Costello J et al. MRI in pelvic inflammatory disease: a pictorial review. Abdominal Radiol 2016; 42 (3): 935–50.
30. Podzolkova N.M. Patogenez, diagnostika i lechenie gnoinykh vospalitel'nykh zabolevanii pridatkov matki. Dis. … d-ra med. nauk. M., 1993; p. 110–6 (in Russian).
31. Janas P, Kucybata I, Padon-Pokracka M, Huras H. Telocytes in female reproductive system: An overview of up-to-date knowledge. Adv Clin Exp Med 2018; 27: 559–65.
32. Varga I, Urban L, Kajanova M, Polak S. Functional histology and possible clinical significance of recently discovered telocytes inside the female reproductive system. Arch Gynecol Obstet 2016; 294: 417–22.
33. Yang J, Chi C, Liu Z et al. Ultrastructure damage of oviduct telocytes in rat model of acute salpingitis, J Cell Mol Med 2015; 19 (7): 1720–8.
34. Enciu AM, Popescu LM. Telopodes of telocytes are influenced in vitro by redox conditions and ageing. Mol Cell Biochem 2015; 410 (1–2): 165–74.
35. Duarte R, Fuhrich D, Ross J. A review of antibiotic therapy for pelvic inflammatory disease. Int J Antimicrob Agents 2015; 46: 272–7.
36. Chappell CA, Wiesenfeld HC. Pathogenesis, Diagnosis, and Management of Severe Pelvic Inflammatory Disease and Tuboovarian Abscess. Clin Obstet Gynecol 2012; 55 (4): 893–903.
37. Chu J, Harb HM, Gallos ID et al. Salpingostomy in the treatment of hydrosalpinx: a systematic review and meta-analysis. Human Rep 2015; 30 (8): 1882–95.
38. Lee MH, Moon MH, Sung CK et al. CT findings of acute pelvic inflammatory disease. Abdom Imag 2014; 39 (6): 1350–5.
39. Levenson RB, Camacho MA, Horn E et al. Eliminating routine oral contrast use for CT in the emergency department: impact on patient throughput and diagnosis. Emerg Radiol 2012; 19 (6): 513–7.
40. Sam JW, Jacobs JE, Birnbaum BA. Spectrum of CT findings in acute pyogenic pelvic inflammatory disease. RadioGraphics 2002; 22 (6): 1327–34.
1 ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России, Москва, Россия;
2 ГБУЗ «Городская клиническая больница им. С.П. Боткина» Департамента здравоохранения г. Москвы, Москва, Россия
*r.e.kuznetsov@yandex.ru
________________________________________________
Roman E. Kuznetsov*1,2, Dariia V. Skripchenko1
1 Russian Medical Academy of Continuous Professional Education, Moscow, Russia;
2 Botkin City Clinical Hospital, Moscow, Russia
*r.e.kuznetsov@yandex.ru